Safety of an Early Discharge Protocol After Sleeve Gastrectomy
1 other identifier
interventional
60
1 country
1
Brief Summary
Evaluate the safety and efficacy of an early discharge protocol (23 hours, overnight stay) after scheduled sleeve gastrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2017
CompletedStudy Start
First participant enrolled
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedMarch 3, 2017
February 1, 2017
1.8 years
February 24, 2017
February 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Readmissions rate
No hospital admissions after surgery
1 month
Secondary Outcomes (4)
Morbidity rate
1 month
Chronogram for complications after surgery
1 month
Quality of life
1 month
Patients agreement to the protocol
1 month
Study Arms (2)
Early discharge group
EXPERIMENTALPatients with a shorter hospital stay, 23 hours after surgery
Conventional discharge
ACTIVE COMPARATORPatients with conventional protocol and 48-72 hours of hospital stay
Interventions
Eligibility Criteria
You may qualify if:
- Patients eligible for Sleeve gastrectomy
- BMI 35 to 50
- ASA I to III
- Conventional address close to our Hospital
- Laparoscopic surgery
- Accompanying person after discharge
- Availability for a smart phone
You may not qualify if:
- ASA IV
- Revisional Surgery
- Conversion to laparotomy
- ICU Admission after surgery
- Insulin dependent Diabetes Mellitus
- Surgery finishing after 3 pm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 24, 2017
First Posted
March 3, 2017
Study Start
March 1, 2017
Primary Completion
December 31, 2018
Study Completion
March 31, 2019
Last Updated
March 3, 2017
Record last verified: 2017-02